Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jun 30, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 1, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000310158-26-000198
Filed / recorded
Jul 1, 2026, 12:41 PM UTC
Added to OQRO
Oct 2, 2026, 3:52 AM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Merck & Co., Inc.
Issuer CIK
310158
Ticker
MRK
Reporting person
Mary Ellen Coe
Relationship
Director
Security
Phantom Stock
Table
Derivative (Table II)
Transaction date
Jun 30, 2026
Transaction code
A
Shares / units
233.463
Price per share
$128.50
Acquired / disposed
Acquired (A)
Shares owned after
31,999.1016
Ownership form
Direct
Amendment
No
Footnotes from the filing
1-for-1
Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
Around the same time
Congress tradeSits on Senate Health, Education, Labor, and Pensions
